serrao6, Author at BioAegis Therapeutics https://www.bioaegistherapeutics.com/author/serrao6/ The Power of Innate Immunity Mon, 24 Nov 2025 17:28:00 +0000 en hourly 1 https://wordpress.org/?v=6.9.4 https://www.bioaegistherapeutics.com/wp-content/uploads/2020/02/cropped-BioAegis-Favicon500-32x32.webp serrao6, Author at BioAegis Therapeutics https://www.bioaegistherapeutics.com/author/serrao6/ 32 32 March 2021: KYW InDepth Podcast – Vaccines are just part of the battle. Good therapeutics are needed to fight COVID-19 as well. https://www.bioaegistherapeutics.com/news/march-2021-kyw-indepth-podcast-vaccines-are-just-part-of-the-battle-good-therapeutics-are-needed-to-fight-covid-19-as-well/?utm_source=rss&utm_medium=rss&utm_campaign=march-2021-kyw-indepth-podcast-vaccines-are-just-part-of-the-battle-good-therapeutics-are-needed-to-fight-covid-19-as-well Sun, 14 Mar 2021 22:11:16 +0000 https://www.bioaegistherapeutics.com/?p=3129 Most of the attention right now is on vaccines, but vaccines are only part of the battle against COVID-19. Dr. Mark DiNubile, Chief Medical Officer at BioAegis, joins KYW Newsradio In Depth to talk about what’s out there right now, the science behind COVID-19 treatments, and why he believes so strongly that gelsolin therapy can […]

The post March 2021: KYW InDepth Podcast – Vaccines are just part of the battle. Good therapeutics are needed to fight COVID-19 as well. appeared first on BioAegis Therapeutics.

]]> February 2021: NIH and Other Independent Studies Confirm Low Levels of BioAegis’ ‘Inflammation Regulator Protein,’ Gelsolin, Associated with COVID-19 Severity https://www.bioaegistherapeutics.com/news/february-2021-nih-and-other-independent-studies-confirm-low-levels-of-bioaegis-inflammation-regulator-protein-gelsolin-associated-with-covid-19-severity/?utm_source=rss&utm_medium=rss&utm_campaign=february-2021-nih-and-other-independent-studies-confirm-low-levels-of-bioaegis-inflammation-regulator-protein-gelsolin-associated-with-covid-19-severity Tue, 02 Feb 2021 19:24:01 +0000 https://www.bioaegistherapeutics.com/?p=3065 MORRISTOWN, N.J., Feb. 02, 2021 (GLOBE NEWSWIRE) — BioAegis Therapeutics Inc., a clinical stage, private company developing therapies for infectious, inflammatory and degenerative diseases through a portfolio built around gelsolin technology, announced today that studies from three independent groups of investigators, including the NIH, have reported that low levels of gelsolin are associated with severity and organ […]

The post February 2021: NIH and Other Independent Studies Confirm Low Levels of BioAegis’ ‘Inflammation Regulator Protein,’ Gelsolin, Associated with COVID-19 Severity appeared first on BioAegis Therapeutics.

]]> November 2020: BioAegis Therapeutics Expands Phase 2 COVID-19 Treatment Clinical Trial in EU for Inflammation Regulator https://www.bioaegistherapeutics.com/news/november-2020-bioaegis-therapeutics-expands-phase-2-covid-19-treatment-clinical-trial-in-eu-for-inflammation-regulator/?utm_source=rss&utm_medium=rss&utm_campaign=november-2020-bioaegis-therapeutics-expands-phase-2-covid-19-treatment-clinical-trial-in-eu-for-inflammation-regulator Sun, 15 Nov 2020 13:18:00 +0000 https://www.bioaegistherapeutics.com/?p=3036 No drug-related safety signals identified by the independent Data and Safety Monitoring Board. MORRISTOWN, N.J., Nov. 15, 2020 (GLOBE NEWSWIRE) — BioAegis Therapeutics Inc., a clinical stage, private company developing therapies for infectious, inflammatory and degenerative diseases through a portfolio built around gelsolin technology, announced that it has expanded its clinical trial in severe COVID-19 […]

The post November 2020: BioAegis Therapeutics Expands Phase 2 COVID-19 Treatment Clinical Trial in EU for Inflammation Regulator appeared first on BioAegis Therapeutics.

]]> August 20, 2020: WIB-Metro New York – Biotech Leadership in the time of COVID-19: Impact, Opportunity, and Resilience https://www.bioaegistherapeutics.com/event/wib-metro-new-york-biotech-leadership-in-the-time-of-covid-19-impact-opportunity-and-resilience/?utm_source=rss&utm_medium=rss&utm_campaign=wib-metro-new-york-biotech-leadership-in-the-time-of-covid-19-impact-opportunity-and-resilience Thu, 20 Aug 2020 18:09:00 +0000 https://www.bioaegistherapeutics.com/?p=2942 The leadership team of BioAegis Therapeutics will share their experiences this year as they reframed their strategy to address the COVID-19 threat to their employees and hustled to initiate a COVID-19 clinical trial for severe COVID-19 patients. When: Thursday, August 20, 2020 12:00 p.m. – 1:00 p.m. EDT Where: Online (GoToWebinar) Contact: WIB-Metro New York […]

The post August 20, 2020: WIB-Metro New York – Biotech Leadership in the time of COVID-19: Impact, Opportunity, and Resilience appeared first on BioAegis Therapeutics.

]]> June 5, 2020: BioNJ COVID-19 Rapid Fire Research Showcase https://www.bioaegistherapeutics.com/event/bionj-covid-19-rapid-fire-research-showcase/?utm_source=rss&utm_medium=rss&utm_campaign=bionj-covid-19-rapid-fire-research-showcase Fri, 05 Jun 2020 11:12:32 +0000 https://www.bioaegistherapeutics.com/?p=2975 BioAegis has been selected as a featured company in the upcoming BioNJ COVID-19 Rapid Fire Research Showcase.  Our Chief Executive Officer and Co-founder, Dr. Susan Levinson, will present our goundbreaking recombinant human plasma gelsolin (rhu-pGSN) therapy. WHEN:    Friday, June 5, 2020, 9:00 a.m. – 10:00 a.m. Register Now

The post June 5, 2020: BioNJ COVID-19 Rapid Fire Research Showcase appeared first on BioAegis Therapeutics.

]]> Steven Cordovano https://www.bioaegistherapeutics.com/leadership/steven-cordovano/?utm_source=rss&utm_medium=rss&utm_campaign=steven-cordovano Tue, 21 Jan 2020 22:25:00 +0000 https://www.bioaegistherapeutics.com/?p=1070 VP, Corporate Development and Communications

The post Steven Cordovano appeared first on BioAegis Therapeutics.

]]> Lester Kobzik, MD https://www.bioaegistherapeutics.com/leadership/lester-kobzik-md/?utm_source=rss&utm_medium=rss&utm_campaign=lester-kobzik-md Tue, 21 Jan 2020 22:20:00 +0000 https://www.bioaegistherapeutics.com/?p=1540 Chief Scientific Advisor

The post Lester Kobzik, MD appeared first on BioAegis Therapeutics.

]]> Valerie Ceva, MBA https://www.bioaegistherapeutics.com/leadership/valerie-ceva-mba/?utm_source=rss&utm_medium=rss&utm_campaign=valerie-ceva-mba Tue, 21 Jan 2020 22:01:00 +0000 https://www.bioaegistherapeutics.com/?p=1066 Chief Operating Officer
Board Member

The post Valerie Ceva, MBA appeared first on BioAegis Therapeutics.

]]> Susan L. Levinson, PhD. https://www.bioaegistherapeutics.com/leadership/susan-levinson-ph-d/?utm_source=rss&utm_medium=rss&utm_campaign=susan-levinson-ph-d Tue, 21 Jan 2020 22:00:00 +0000 https://www.bioaegistherapeutics.com/?p=1064 Chief Executive Officer
Board Member

The post Susan L. Levinson, PhD. appeared first on BioAegis Therapeutics.

]]> Steven Opal, M.D. (In Memoriam) https://www.bioaegistherapeutics.com/clinical/steven-opal-m-d/?utm_source=rss&utm_medium=rss&utm_campaign=steven-opal-m-d Tue, 21 Jan 2020 15:00:00 +0000 https://www.bioaegistherapeutics.com/?p=995 In Memoriam

The post Steven Opal, M.D. (In Memoriam) appeared first on BioAegis Therapeutics.

]]>